PYY is another candidate for the short-term control of food intake (64, 65) that originates from the L-cells in the ileal and colon mucosa following stimulation by feeding, particularly when ingested nutrients, namely fatty acids, reach the distal portion of the small bowel and colon (66)
a trend which continued, resulting in a close to twenty-fold increase 17.9% in incident semaglutide patients between 2019 and 2023
New insights into Beta-cell GLP-1 receptor and cAMP signaling
Most research peptides come from Chinese peptide manufacturers where production costs are lower but quality control is inconsistent
Walker says, GLP-1 RAs are not an FDA-cleared treatment for dermatologic use
Insulin sensitivity restoration and hair health The tirzepatide case report showing hair regrowth in an insulin-resistant patient raises an important question